Covid 19 Detection Poc Kits Market Report: Market Size & Forecast 2026

The market includes COVID-19 detection kits designed for point-of-care use, enabling fast results outside traditional laboratories. These kits use various sample types including nasopharyngeal swabs, oropharyngeal swabs, saliva, and blood. They serve hospitals, diagnostic labs, clinics, and other healthcare settings.

• •Market valued at approximately $7.8 billion in 2025 with 3.5% annual growth projected
• •Products include RT-PCR kits, antigen detection kits, and antibody detection kits
• •Sample types range from nasopharyngeal swabs and oropharyngeal swabs to saliva and blood

Ongoing COVID-19 surveillance and the need to track new variants continue to drive demand for detection kits. The shift toward decentralized testing and rapid results in clinical settings supports market expansion. Additionally, investments in healthcare infrastructure and pandemic preparedness in many countries contribute to sustained demand.

• •Continued need for SARS-CoV-2 variant tracking and surveillance worldwide
• •Preference for rapid point-of-care testing over centralized laboratory testing
• •Government and institutional investments in pandemic preparedness infrastructure

The market is segmented by product type, detection technology, sample type, distribution channel, application, and end user. Molecular tests, particularly RT-PCR, represent a significant portion of the market, while antigen tests dominate the rapid testing segment. Geographically, North America and Europe lead in market share due to established healthcare infrastructure, while Asia-Pacific shows growing demand.

• •Key segments include molecular tests (RT-PCR), antigen tests, and antibody tests
• •End users include hospitals, diagnostic laboratories, clinics, and point-of-care centers
• •North America and Europe hold the largest market shares, with Asia-Pacific expanding

What are the recent trends and outlook?

The market is expected to maintain steady growth as COVID-19 becomes endemic and routine surveillance continues. Advances in testing technology, including improved isothermal amplification and multiplex capabilities, are shaping product development. Integration with digital health platforms and simplified sample collection methods are also emerging as key trends.

• •Shift toward endemic management with routine surveillance driving consistent demand
• •Advances in isothermal amplification and multiplex test technologies
• •Growing integration of testing results with digital health platforms and telehealth